South African Variant May “Break Through” Pfizer Vaccine Protection, Says Study

0
117
The South African variant, B.1.351, was found to make up about 1% of all the COVID-19 cases globally studied, as per the study by Tel Aviv University and Israel’s largest healthcare provider, Clalit.

LEAVE A REPLY

Please enter your comment!
Please enter your name here